These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34665908)

  • 1. Total Syntheses of Conjugation-Ready Repeating Units of Acinetobacter baumannii AB5075 for Glycoconjugate Vaccine Development.
    Zhang S; Seeberger PH
    Chemistry; 2021 Dec; 27(69):17444-17451. PubMed ID: 34665908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total Syntheses of Conjugation-Ready Trisaccharide Repeating Units of
    Behera A; Rai D; Kulkarni SS
    J Am Chem Soc; 2020 Jan; 142(1):456-467. PubMed ID: 31815459
    [No Abstract]   [Full Text] [Related]  

  • 3. Semi-Synthetic Glycoconjugate Vaccine Lead Against Acinetobacter baumannii 17978.
    Sianturi J; Priegue P; Hu J; Yin J; Seeberger PH
    Angew Chem Int Ed Engl; 2022 Oct; 61(41):e202209556. PubMed ID: 35950629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total Synthesis of Conjugation-Ready Tetrasaccharide Repeating Units of a Multidrug-Resistant Pathogen
    Rai D; Kulkarni SS
    Org Lett; 2023 Nov; 25(46):8332-8337. PubMed ID: 37955403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineating the Plausible Molecular Vaccine Candidates and Drug Targets of Multidrug-Resistant
    Mujawar S; Mishra R; Pawar S; Gatherer D; Lahiri C
    Front Cell Infect Microbiol; 2019; 9():203. PubMed ID: 31281799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Unprecedented Tolerance to Deletion of the Periplasmic Chaperones SurA, Skp, and DegP in the Nosocomial Pathogen Acinetobacter baumannii.
    Birkle K; Renschler F; Angelov A; Wilharm G; Franz-Wachtel M; Maček B; Bohn E; Weber E; Müller J; Friedrich L; Schütz M
    J Bacteriol; 2022 Oct; 204(10):e0005422. PubMed ID: 36106853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AB5075, a Highly Virulent Isolate of Acinetobacter baumannii, as a Model Strain for the Evaluation of Pathogenesis and Antimicrobial Treatments.
    Jacobs AC; Thompson MG; Black CC; Kessler JL; Clark LP; McQueary CN; Gancz HY; Corey BW; Moon JK; Si Y; Owen MT; Hallock JD; Kwak YI; Summers A; Li CZ; Rasko DA; Penwell WF; Honnold CL; Wise MC; Waterman PE; Lesho EP; Stewart RL; Actis LA; Palys TJ; Craft DW; Zurawski DV
    mBio; 2014 May; 5(3):e01076-14. PubMed ID: 24865555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total Synthesis of a Densely Functionalized Plesiomonas shigelloides Serotype 51 Aminoglycoside Trisaccharide Antigen.
    Qin C; Schumann B; Zou X; Pereira CL; Tian G; Hu J; Seeberger PH; Yin J
    J Am Chem Soc; 2018 Feb; 140(8):3120-3127. PubMed ID: 29377682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency And Clinical Spectrum Of Multidrug Resistant Acinetobacter Baumannii As A Significant Nosocomial Pathogen In Intensive Care Unit Patients.
    Sana F; Hussain A; Hussain W; Zaman G; Abbas MW; Imtiaz A; Satti L
    J Ayub Med Coll Abbottabad; 2021; 33(Suppl 1)(4):S752-S756. PubMed ID: 35077621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit.
    Shi J; Sun T; Cui Y; Wang C; Wang F; Zhou Y; Miao H; Shan Y; Zhang Y
    BMC Infect Dis; 2020 Aug; 20(1):597. PubMed ID: 32787942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of oxacillinase genes in nosocomial multidrug-resistant Acinetobacter baumannii isolates by multiplex PCR and evaluation of their clonal relationship with Rep-PCR].
    Sarı B; Baran I; Alaçam S; Mumcuoğlu İ; Kurşun Ş; Aksu N
    Mikrobiyol Bul; 2015 Apr; 49(2):249-58. PubMed ID: 26167825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure elucidation of the capsular polysaccharide of Acinetobacter baumannii AB5075 having the KL25 capsule biosynthesis locus.
    Senchenkova SN; Shashkov AS; Popova AV; Shneider MM; Arbatsky NP; Miroshnikov KA; Volozhantsev NV; Knirel YA
    Carbohydr Res; 2015 May; 408():8-11. PubMed ID: 25816997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Acinetobacter baumannii severe infections.
    Reina R; León-Moya C; Garnacho-Montero J
    Med Intensiva (Engl Ed); 2022 Dec; 46(12):700-710. PubMed ID: 36272902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug treatment for multidrug-resistant Acinetobacter baumannii infections.
    Bassetti M; Righi E; Esposito S; Petrosillo N; Nicolini L
    Future Microbiol; 2008 Dec; 3(6):649-60. PubMed ID: 19072182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Acinetobacter infections.
    Michalopoulos A; Falagas ME
    Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nosocomial infection by sequence type 357 multidrug-resistant Acinetobacter baumannii isolates in a neonatal intensive care unit in Daejeon, Korea.
    Sung JY; Koo SH; Cho HH; Kwon KC
    Ann Lab Med; 2013 Jul; 33(4):279-82. PubMed ID: 23826565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative proteomics analyses of Acinetobacter baumannii strains ATCC 17978 and AB5075 reveal the differential role of type II secretion system secretomes in lung colonization and ciprofloxacin resistance.
    Elhosseiny NM; Elhezawy NB; Attia AS
    Microb Pathog; 2019 Mar; 128():20-27. PubMed ID: 30578836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acinetobacter baumannii: an emerging multidrug-resistant threat.
    Gootz TD; Marra A
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):309-25. PubMed ID: 18588496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rare occurrence of multidrug-resistant environmental Acinetobacter baumannii strains from the soil of Mangaluru, India.
    Suresh S; Aditya V; Deekshit VK; Manipura R; Premanath R
    Arch Microbiol; 2022 Jun; 204(7):422. PubMed ID: 35750869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing Screen Identifies Unconventional Drugs With Activity Against Multidrug Resistant
    Cheng YS; Sun W; Xu M; Shen M; Khraiwesh M; Sciotti RJ; Zheng W
    Front Cell Infect Microbiol; 2018; 8():438. PubMed ID: 30662875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.